ARHGEF11: Rho Guanine Nucleotide Exchange Factor 11

A key regulator of Rho GTPase signaling in neuronal and cancer biology

Gene Information Card

Symbol ARHGEF11
Full Name Rho guanine nucleotide exchange factor 11
Gene Type protein-coding
Chromosomal Location 1q23.3
NCBI Gene ID 9826 ncbi.nlm.nih.gov/gene/9826
Ensembl ID ENSG00000132694
UniProt ID O15085
OMIM ID 605707
HGNC ID 681
Aliases PDZ-RhoGEF, KIAA0380, GEF11

Description

ARHGEF11 encodes a Rho guanine nucleotide exchange factor (GEF) that activates Rho GTPases, particularly RhoA, by catalyzing the exchange of GDP for GTP. The protein contains a PDZ domain, a regulator of G protein signaling (RGS) domain, and a Dbl homology (DH) domain. It is highly expressed in the brain and plays critical roles in neuronal development, axon guidance, and synaptic plasticity. Mutations in ARHGEF11 are associated with hereditary spastic paraplegia and have been implicated in glioma and other cancers.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Hereditary spastic paraplegia (SPG86) Loss-of-function mutations impair RhoA activation, leading to axonal degeneration PMID: 32098966
Glioma Overexpression or gain-of-function promotes cell migration and invasion via RhoA/ROCK signaling PMID: 25652368
Amyotrophic lateral sclerosis (ALS) Rare variants may disrupt motor neuron function PMID: 27745833

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 38.2 High
Spinal cord 22.5 Medium
Testis 15.1 Medium
Lung 8.3 Low
Liver 3.7 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 45.6 High expression
U87MG (glioblastoma) 52.1 High expression
HEK293 (embryonic kidney) 12.3 Moderate expression
HeLa (cervical carcinoma) 8.9 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.277C>T (p.Arg93Trp) Missense Rare Loss of GEF activity; associated with HSP
c.1246G>A (p.Gly416Arg) Missense Rare Impaired RhoA activation; linked to ALS
c.1891_1893del (p.Glu631del) In-frame deletion Somatic (glioma) Gain-of-function; increased cell migration
Mutation functional classification

Loss of Function (LOF)

Missense mutations in the DH domain (e.g., p.Arg93Trp) reduce RhoA-GEF activity, leading to axonal degeneration in hereditary spastic paraplegia.

Gain of Function (GOF)

Somatic deletions (e.g., p.Glu631del) enhance RhoA activation, promoting glioma cell invasion.

Dominant Negative (DN)

Not well characterized; some missense variants may act dominant-negative by sequestering upstream activators.

Gene Ontology (GO)

• Rho guanyl-nucleotide exchange factor activity • GTPase activator activity
• PDZ domain binding • Rho protein signal transduction
• actin cytoskeleton organization • neuron projection morphogenesis

Pathways

RhoA signaling pathway
Axon guidance
G protein-coupled receptor signaling
Regulation of actin cytoskeleton

Protein Summary

ARHGEF11 (PDZ-RhoGEF) is a 1522-amino acid protein that localizes to the cytoplasm and plasma membrane. It contains a PDZ domain for protein-protein interactions, an RGS domain that modulates G protein signaling, and a tandem DH-PH domain responsible for RhoA exchange activity. The protein is essential for RhoA-mediated cytoskeletal remodeling, cell adhesion, and migration. In the nervous system, it regulates dendritic spine morphology and axonal outgrowth. Dysregulation of ARHGEF11 contributes to neurodegenerative diseases and cancer progression.

Related Products

Product name Cat.No. Species Gene ID
ARHGEF11 Knockout HEK293 Cell Line EDJ-KQ6765 Human 9826 Details Get a Quote
ARHGEF11 Knockout HCT 116 Cell Line EDJ-KQ31205 Human 9826 Details Get a Quote
ARHGEF11 Knockout HeLa Cell Line EDJ-KQ31206 Human 9826 Details Get a Quote
ARHGEF11 Knockout A-549 Cell Line EDJ-KQ29850 Human 9826 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: